← Latest papers
📄 chemistry

Stability Indicating HPTLC Method Development and Validation for Simultaneous Estimation of Polmacoxib and Paracetamol in Bulk and tablet dosage form

This paper presents the development and validation of a simple, accurate, and stability-indicating HPTLC method for the simultaneous quantification of Polmacoxib and Paracetamol in bulk and tablet formulations, demonstrating excellent linearity, specificity, and robustness under various stress conditions.

Original authors: Arun Maruti Kashid, Rucha Ravikiran Takalkar, Jayshree Kailas Kokane, Pranav Kailas Deore

Published 2026-08-20
📖 4 min read☕ Coffee break read

Original authors: Arun Maruti Kashid, Rucha Ravikiran Takalkar, Jayshree Kailas Kokane, Pranav Kailas Deore

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer

Pain and inflammation are universal human experiences, often managed by medications that target the body's chemical signals. Two common classes of drugs used for this purpose are nonsteroidal anti-inflammatory drugs, which reduce swelling and pain, and analgesics, which relieve discomfort and fever. Sometimes, doctors prescribe these two types of drugs together in a single pill to tackle both issues at once, hoping to improve relief while keeping side effects low. However, for such a combination to be safe and effective, manufacturers must be able to prove exactly how much of each drug is present in every tablet and ensure that the ingredients remain stable over time. This requires precise analytical tools capable of separating and measuring the two distinct chemicals, even when they are mixed together in a complex pill.

In a recent study, researchers developed a new method to perform this exact task for a specific combination of two medicines: polmacoxib, a newer drug that targets inflammation, and paracetamol, a widely used pain reliever. The team, working at the Sinhgad Institute of Pharmacy in India, created a technique called high-performance thin-layer chromatography. This process is essentially a sophisticated way of separating mixtures. Imagine a drop of ink placed on a strip of paper; as a liquid solvent travels up the paper, the different colors in the ink move at different speeds and separate into distinct bands. In this study, the researchers used a similar principle but with a specialized glass plate coated in a fine layer of silica gel and a computer-controlled system to measure the results with extreme precision.

The researchers began by determining the best conditions to separate polmacoxib and paracetamol. They tested various mixtures of liquids to find the one that would carry the two drugs up the plate at different rates, ensuring they did not overlap. They found that a mixture of toluene, ethyl acetate, and formic acid worked best. When they applied the drugs to the plate and let this liquid travel up the surface, the polmacoxib traveled slightly further than the paracetamol, creating two clear, separate spots. The team then used a scanner to detect these spots by shining ultraviolet light on them, specifically at a wavelength where both drugs absorb light strongly. This allowed them to measure the amount of each drug present based on the intensity of the signal.

To ensure this method was reliable for everyday use in pharmaceutical quality control, the team subjected it to a rigorous series of tests. They checked if the method could accurately measure the drugs in pure form and in actual tablets. They confirmed that the results were consistent whether the tests were run on the same day or on different days, and whether different people performed the analysis. The method proved to be highly sensitive, capable of detecting even tiny amounts of the drugs, and robust enough to withstand small changes in the experimental conditions without producing errors. Most importantly, they tested the drugs under harsh conditions, such as exposure to strong acids, bases, heat, and light, to see if the method could still distinguish the original medicines from any broken-down parts.

The results showed that the new method successfully separated the two drugs from their degradation products, proving it could act as a "stability-indicating" tool. This means it can tell the difference between the healthy medicine and the medicine that has started to break down, a critical capability for ensuring patient safety. When the researchers applied their method to commercial tablets containing the drug combination, the results matched the expected amounts of polmacoxib and paracetamol almost perfectly. The study concludes that this technique is a simple, accurate, and cost-effective way to monitor the quality of these medications, ensuring that every tablet contains the correct dose and remains stable throughout its shelf life.

Drowning in papers in your field?

Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.

Try Digest →